Prioritising Biospecimen Management before the Protocol Locks: A Cross-Stakeholder Framework for Better Planning

About this session

This panel brings together members of the Biospecimen Management Consortium (BMC) to share the organization's work toward elevating biospecimen management as a strategic function in clinical research, exploring challenges and solutions associated with standardizing study planning practices across the clinical trial ecosystem. Discussions will encompass cross-document alignment (protocol, biospecimen plan, and lab manual), stakeholder coordination across sponsors, sites, and laboratories, and the development of industry baseline guidelines.

Speakers

• 

  Karina Bienfait

  Executive Director, Consent, Biospecimen & Imaging Management · Bristol Myers Squibb Co.

  Speaker

• 

  Amy Ripston

  Founder & President · Biospecimen Management Consortium

  Speaker

• GS

  Grigori Singovski

  Biosample Project Lead · Hoffmann-La Roche

  Speaker

• DS

  Diana Steinbuesch

  BioX Operations Portfolio Lead (Oncology) · Roche

  Speaker